Neurofarba, Pharmaceutical and Nutraceutical Section, University of Florence, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Italy.
CNR-Institute of Neuroscience, Cagliari, Cittadella Universitaria, 09042 Monserrato, Italy.
Int J Mol Sci. 2024 Oct 9;25(19):10840. doi: 10.3390/ijms251910840.
As a continuation of our study in the field of GABA receptor modulators, we report the design and synthesis of new pyrazolo[1,5-a]quinazoline (PQ) bearing at the 8-position an oxygen or nitrogen function. All the final compounds and some intermediates, showing the three different forms of the pyrazolo[1,5-a]quinazoline scaffold (5-oxo-4,5-dihydro, -4,5-dihydro, and heteroaromatic form), have been screened with an electrophysiological technique on recombinant GABAR (α1β2γ2-GABAR), expressed in oocytes, by evaluating the variation in produced chlorine current, and permitting us to identify some interesting compounds (, , , and ) on which further functional assays were performed. Molecular modelling studies (docking, minimization of complex ligand-receptor, and MD model) and a statistical analysis by a Hierarchical Cluster Analysis (HCA) have collocated these ligands in the class corresponding to their pharmacological profile. The HCA results are coherent with the model we recently published (Proximity Frequencies), identifying the residues γThr142 and αHis102 as discriminant for the agonist and antagonist profile.
作为我们在 GABA 受体调节剂领域研究的延续,我们报告了新的吡唑并[1,5-a]喹唑啉(PQ)的设计和合成,其在 8 位带有氧或氮官能团。所有最终化合物和一些中间体,展示了吡唑并[1,5-a]喹唑啉支架的三种不同形式(5-氧代-4,5-二氢、4,5-二氢和杂芳环形式),已经通过在表达于卵母细胞中的重组 GABAR(α1β2γ2-GABAR)上进行的电生理技术进行了筛选,通过评估产生的氯电流的变化,使我们能够识别出一些有趣的化合物(、、和),并对其进行了进一步的功能测定。分子建模研究(对接、配体-受体复合物的最小化和 MD 模型)和通过层次聚类分析(HCA)的统计分析将这些配体归为与其药理学特征相对应的类别。HCA 结果与我们最近发表的模型(邻近频率)一致,确定了γThr142 和 αHis102 残基作为激动剂和拮抗剂特征的判别因子。